Atlas Trials

Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial

Clinical trial NCT03790293 · COMPLETED

Trial details

NCT number
NCT03790293
Sponsor
University Hospital, Rouen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Autoimmune Diseases
Start date
2018-11-17
Primary completion
2019-04-19
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.